menu
    • menu

    Company profile for Avicanna

    NEW Drugs in Dev: 5
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Avicanna is a Canadian biopharmaceutical company providing the global marketplace with advanced natural cannabinoid solutions through an evidence-based approach offered across several product platforms including API, medical, pharmaceutical, and dermacosmetic. As a multinational organization with vertical integration , Avicanna is focused on utilizing the scientific research related to plant-derived cannabinoid products throug...
    Avicanna is a Canadian biopharmaceutical company providing the global marketplace with advanced natural cannabinoid solutions through an evidence-based approach offered across several product platforms including API, medical, pharmaceutical, and dermacosmetic. As a multinational organization with vertical integration , Avicanna is focused on utilizing the scientific research related to plant-derived cannabinoid products through its internal research platforms and strategic collaborations with world-class research institutions.To provide unparalleled quality of natural cannabinoids solutions that foster informed communities

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AvicannaCanada Flag
    Country
    Country
    Canada
    Address
    Address
    480 University Ave, Suite 1502 Toronto, ON M5G 1V2
    Telephone
    Telephone
    647.243.5283
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.avicanna.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/avicanna/?originalSubdomain=ca
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/avicannainc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Avicanna Releases Medical Cannabis Real-World Evidence Findings
    Avicanna Releases Medical Cannabis Real-World Evidence Findings

    30 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/30/3229463/0/en/Avicanna-Announces-Medical-Cannabis-Real-World-Evidence-Results-and-Publication.html

    GLOBENEWSWIRE
    30 Jan 2026
    Share Share
    Avicanna Announces Changes To Its Board Of Directors
    Avicanna Announces Changes To Its Board Of Directors

    23 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/23/3209803/0/en/Avicanna-Announces-Changes-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    23 Dec 2025
    Share Share
    Avicanna Hails Trump Cannabis Reclass, Shares Science Update
    Avicanna Hails Trump Cannabis Reclass, Shares Science Update

    19 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/19/3208434/0/en/Avicanna-Applauds-President-Trump-s-Executive-Order-to-Reclassify-Cannabis-Provides-Scientific-Update.html

    GLOBENEWSWIRE
    19 Dec 2025
    Share Share
    Avicanna Unveils Pre-Clinical Data Backing Novel Oral Delivery
    Avicanna Unveils Pre-Clinical Data Backing Novel Oral Delivery

    19 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/19/3190836/0/en/Avicanna-Announces-Pre-Clinical-Data-Supporting-Enhanced-Absorption-and-Patent-Filing-for-Novel-Oral-Delivery-Platform.html

    GLOBENEWSWIRE
    19 Nov 2025
    Share Share
    Avicanna Reports Q3 2025
    Avicanna Reports Q3 2025

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188661/0/en/Avicanna-Reports-Q3-2025.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share
    Avicanna Reveals CFO Change
    Avicanna Reveals CFO Change

    12 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/12/3149461/0/en/Avicanna-Announces-Change-in-CFO.html

    GLOBENEWSWIRE
    12 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search